Chapter 2 - Neoplasms (C00-D49)»Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)»Chronic myeloproliferative disease (D47.1)
D47.1
Chronic myeloproliferative disease
Related indications (MeSH) (2)
Leukemia, Neutrophilic, Chronic37 drugs (32 approved, 5 experimental)
A rare myeloproliferative disorder that is characterized by a sustained, mature neutrophilic leukocytosis. No monocytosis, EOSINOPHILIA, or basophilia is present, nor is there a PHILADELPHIA CHROMOSOME or bcr-abl fusion gene (GENES, ABL).
Myeloproliferative Disorders303 drugs (181 approved, 122 experimental)
Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.